Day: December 22, 2025
Transparency notification by JP Morgan Asset Management Holdings Inc.
In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by JP Morgan Asset Management Holdings Inc. that its subsidiary JP Morgan Asset Management (UK) Limited has crossed the legal threshold of 3% for the direct voting rights and equivalent financial instruments upwards on 15 December 2025.
The total holding of direct voting rights and equivalent financial instruments of JP Morgan Asset Management Holdings Inc. stands at 3.41% on 15 December 2025.
Summary of the move by JP Morgan Asset Management (UK) Limited, a subsidiary of JP Morgan Asset Management Holdings Inc:Date on which the threshold was crossed
Date of notification
Direct voting rights after the transaction
Equivalent financial instruments...
Tevogen CEO Donates Shares to Support Education for Underprivileged Children
Written by Customer Service on . Posted in Public Companies.
WARREN, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi has made a charitable contribution of 230,000 shares of Tevogen common stock to SRLC USA, a United Nations-recognized 501(c)(3) nonprofit organization dedicated to serving underserved communities.
“Education is one of the most powerful long-term investments we can make in building healthier, more equitable societies,” said Dr. Saadi. “I’m pleased to support an organization that is deeply committed to uplifting underserved communities through meaningful, measurable action.”
The donation was conducted in accordance with SEC Rule 144 and Dr. Saadi will not receive any proceeds from the disposal of the securities.
About Tevogen
Tevogen is a next-generation, socially...
Bimergen Energy Uplist to the NYSE American Stock Exchange with Concurrent Offering to Occur upon SEC Effectiveness
Written by Customer Service on . Posted in Public Companies.
Newport Beach, CA, Dec. 22, 2025 (GLOBE NEWSWIRE) — Bimergen Energy Corporation (OTCQB: BESS) (“Bimergen”), a utility-scale battery energy storage systems (BESS) asset owner, project developer, and independent power provider, today announced that its shares of common stock have been approved for listing on the NYSE American LLC (“NYSE American”) stock exchange. Bimergen expects that its common stock will begin trading on the NYSE American under the symbol “BESS” upon effectiveness of its registration statement and authorization of the application and continued satisfaction of NYSE American rules.
In connection with the anticipated uplisting, Bimergen is also conducting a concurrent offering of its securities, subject to market conditions. Additional details regarding the offering will be provided through the Company’s...
Sanofi: Information concerning the total number of voting rights and shares – November 2025
Written by Customer Service on . Posted in Public Companies.
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)
Sanofia French société anonyme with a registered share capital of €2,438,854,192Registered office : 46, avenue de la Grande Armée – 75017 Paris – FranceRegistered at the Paris Commercial and Companies Registry under number 395 030 844Date
Total number of issued shares
Number of real voting rights(excluding treasury shares)
Theoretical number of voting rights (including treasury shares)*30 November 2025
1,227,469,992
1,345,585,094
1,361,665,420* Pursuant to Article 223-11 of the Règlement général de l’Autorité des Marchés...
Orrön Energy sells a portfolio of three solar energy projects in Germany for a total consideration of up to MEUR 14
Written by Customer Service on . Posted in Public Companies.
Orrön Energy AB (“Orrön Energy” or “the Company”) is pleased to announce that it has entered into an agreement with Gülermak Renewables Deutschland Holding GmbH (“Gülermak”), 100% subsidiary of Gülermak Renewables Ltd to sell three solar energy development projects in Germany, with a combined estimated installed capacity of 234 MW, for a total consideration of up to MEUR 14. The consideration paid at closing for the first project is expected to be MEUR 0.7, with the remaining consideration contingent on development milestones being met up to the ready-to-build stage.
The projects are located in eastern Germany and are being developed as Agri-PV projects with co-located battery options, enabling agricultural activities to take place alongside solar power generation. The projects are in a pre-ready-to-permit stage and are being developed...
Beamr’s Benchmark Testing Validates ML-Safe Video Data Workflows for Autonomous Vehicles
Written by Customer Service on . Posted in Public Companies.
Testing demonstrates 48% file size reduction with robust ML model accuracy across multiple industry-standard metrics. AV teams are invited to meet Beamr at CES 2026, January 6-9 in Las Vegas
Herzliya, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, published benchmark testing results validating that its patented Content-Adaptive Bitrate (CABR) technology delivers up to 50% storage reduction for autonomous vehicle (AV) video data with comprehensive technical demonstration of machine learning (ML) model accuracy.
AV teams and developers attending CES 2026 in Las Vegas, from January 6-9, 2026, are invited to schedule a meeting with Beamr’s video data experts to review the results and discuss ML-safe AV pipelines. To schedule a meeting at CES 2026,...
AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040
Written by Customer Service on . Posted in Public Companies.
PRESS RELEASE
AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2040
THIS DECISION STRENGTHENS MASITINIB’S INTELLECTUAL PROPERTY PORTFOLIO WITH LONG-TERM PROTECTION FOR AN ADDITIONAL INDICATION WITH A HIGH UNMET MEDICAL NEED
THE BIOMARKER PHASE 2 IN COOPERATION WITH AP-HP IS FULLY FUNDED
Paris, December 22, 2025, 6pm CET
AB Science SA (Euronext – FR0010557264 – AB) today announced that the United States Patent Office has formally granted a patent for methods of treating sickle cell disease (i.e., a medical use patent) using its lead compound masitinib, based on preclinical data. This new US patent (US12,472,164) ensures intellectual property protection for masitinib until November 2040.Masitinib : An innovation in sickle cell diseaseSickle...
Aramis Group – Declaration of transactions on own shares conducted from Dec 15 to Dec 19, 2025
Written by Customer Service on . Posted in Public Companies.
PRESS RELEASE
Arcueil, December 22, 2025
Declaration of transactions on own shares conducted from December 15 to December 19, 2025
Within the framework of the authorizations granted by the General Assembly on February 4, 2025, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from December 15 to December 19, 2025 (excluding the liquidity contract):Name of the issuer
Issuer identifier code
Transaction date
Financial instrument identifier code
Total daily volume (in number of shares)
Daily weighted average purchase price of shares
MarketAramis Group
9695002Q984W0T41WB42
2025-12-15
FR0014003U94
4,577
4.3694
XPARAramis Group
9695002Q984W0T41WB42
2025-12-16
FR0014003U94
4,620
4.3287
XPARAramis Group
9695002Q984W0T41WB42
2025-12-17
FR0014003U94
4,687
4.2671
XPARAramis...
Solo Brands, Inc. Announces Corporate Simplification to Establish a Single Class of Common Stock and Limit Its Tax Receivable Agreement
Written by Customer Service on . Posted in Public Companies.
Strategic Actions to Align with Shareholders’ Interests and Significant Cash Savings Expected
GRAPEVINE, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) — Solo Brands, Inc. (NYSE: SBDS) (“Solo Brands” or “the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru) that are redefining the outdoor and apparel industries, announced that it is conducting a series of transactions that will simplify its organizational structure, including the elimination of its umbrella partnership C corporation (Up-C) structure, which has the effect of limiting material liability for potential cash payments under its Tax Receivable Agreement (the “TRA”).
“We are simplifying our corporate structure to strengthen governance and align with shareholder interests. Capping the tax receivable agreement lowers future obligations,...
MicroCloud Hologram Inc. Develops Serial-Parallel Architecture-Based FPGA Quantum Computing Simulation Framework
Written by Customer Service on . Posted in Public Companies.
SHENZHEN, China, Dec. 22, 2025 (GLOBE NEWSWIRE) — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, launched a brand-new FPGA-based quantum computing simulation framework founded on a serial-parallel architecture. This framework adopts an innovative hardware-level data path design and, by redefining the execution mode of quantum gate operations, achieves a linear reduction in resource utilization.
This framework not only demonstrates the inherent advantages of hardware-simulated quantum systems in terms of speed and parallelism but also marks a key step taken by HOLO in the direction of quantum computing hardware acceleration. This technology has been validated on core quantum algorithms such as Quantum Fourier Transform (QFT) and Grover Search, providing a scalable path...
